Action COST B15
Molecular Modelling of Drug Targets
In silico Predictions of Drug Solubility and Permeability
Which in vitro Screens Guide the Prediction of Oral Absorption and Volume of Distribution?
Prediction of Drug Metabolism and Interactions on the Basis of in vitro Investigations
The Use of in vitro Data in Risk Assessment
On the Prediction of the Human Response
Application of Full Physiological Models for Pharmaceutical Drug Candidate Selection and Extrapolation of Pharmacokinetics to Man
Modeling and Monte Carlo Simulations in Oral Drug Absorption
Pharmacokinetic/Pharmacodynamic Modelling in Oncological Drug Development
Mechanism-Based Modeling of Complex Biomedical Systems
The Odds that Clinically Unrecognized Poor or Partial Adherence Confuses Population Pharmacokinetic/Pharmacodynamic Analyses
Clinical Trial Simulation
Predicting the Outcome of Phase III Trials using Phase II Data
Internal Exposure of Children by Simulated Acute Inhalation of Volatile Organic Compounds
Model Systems Based on Experimental Animals for Studies on Drug Metabolism in Man
Pupil Reaction
Low-Dose Methotrexate Pharmacokinetics and Pharmacodynamics in the Therapy of Severe Psoriasis
Expression of MRP2 and MDR1 and Other Hepatic Markers in Hepatocytes in situ and WRL 68 Cells in vitro
Predictive Model for Identifying Potential CYP2D6 Inhibitors
Evaluation of a Physiologically-Based Pharmacokinetic Approach for Simulating the First-Time-In-Animal Study
The Effect of Mdr1 Induction on the Pharmacokinetics of Rhodamine 123 in Rats
Non-Standard Correlations
Dissolution – Bioequivalence Non-Correlations
A Pharmacokinetic-Pharmacodynamic Model for Predicting Tumour Growth Inhibition in Mice
Optimizing Drug Regimens in Cancer Chemotherapy